OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$222M
AUM Growth
-$100M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
56
New
Increased
Reduced
Closed

Top Buys

1
+$8.18M
2
+$6.7M
3
+$5.54M
4
URGN icon
UroGen Pharma
URGN
+$1.96M
5
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$1.94M

Top Sells

1
+$9.3M
2
+$7.68M
3
+$6.78M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$5.96M
5
CYTK icon
Cytokinetics
CYTK
+$4.09M

Sector Composition

1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$24.3M 10.94%
3,332,732
+41,389
2
$24M 10.83%
5,974,800
3
$13.5M 6.07%
1,288,450
-56,550
4
$12.5M 5.64%
671,300
-21,700
5
$11.9M 5.36%
302,500
-104,000
6
$11.5M 5.19%
1,643,367
+1,166,367
7
$8.88M 4%
2,684,167
+10,136
8
$8.25M 3.72%
206,266
+48,511
9
$7.89M 3.56%
814,250
-298,250
10
$7.65M 3.45%
338,000
11
$7.63M 3.44%
276,000
+10,250
12
$6.7M 3.02%
+590,000
13
$6.45M 2.91%
2,462,500
+83,225
14
$5.86M 2.64%
263,050
-7,950
15
$5.58M 2.52%
183,750
-223,252
16
$5.54M 2.5%
+147,700
17
$4.84M 2.18%
41,880
+13,480
18
$4.13M 1.86%
190,000
-21,000
19
$3.86M 1.74%
2,099,971
-295,629
20
$3.59M 1.62%
451,400
+148,400
21
$3.43M 1.54%
166,406
22
$2.97M 1.34%
1,430,000
-4,473,450
23
$2.73M 1.23%
216,479
-33,521
24
$2.43M 1.09%
90,000
-105,500
25
$2.27M 1.03%
521,500
+342,700
1
2 3